Novel histopathological biomarkers in prostate cancer: implications and perspectives

P Kiełb, K Kowalczyk, A Gurwin, Ł Nowak, W Krajewski… - Biomedicines, 2023 - mdpi.com
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …

[HTML][HTML] Deep UV microscopy identifies prostatic basal cells: an important biomarker for prostate cancer diagnostics

O OsunkoyaAdeboye, E RoblesFrancisco - BME frontiers, 2022 - spj.science.org
Abstract Objective and Impact Statement. Identifying benign mimics of prostatic
adenocarcinoma remains a significant diagnostic challenge. In this work, we developed an …

Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection …

M Eslami, T Khamechian, T Mazoochi, H Ehteram… - Springerplus, 2016 - Springer
Background Survivin is a newly found member of the inhibitors of apoptosis proteins, which
plays a certain role in cancer. Survivin has a distinctly different expression in cancers …

The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana

P Ramatlho, MM Rugemalila, L Tawe… - … and Reports in …, 2025 - Taylor & Francis
Introduction Prostate cancer (CaP) is the most common malignancy and the second leading
cause of cancer-related deaths among men in Botswana. Currently, diagnosing CaP relies …

[PDF][PDF] Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives. Biomedicines 2023, 11, 1552. htps

P Kiełb, K Kowalczyk, A Gurwin, Ł Nowak… - doi. org/10.3390 …, 2023 - researchgate.net
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the
significant progress in cancer diagnosis and treatment over the last few years, the approach …

[PDF][PDF] Evaluation of mucin histochemistry in relation to p63 expression in nodular hyperplasia and adenocarcinoma of prostate

RA Sweety, S Sultana, MA Islam… - International Journal of …, 2023 - academia.edu
Background: Prostate cancer is a leading cause of death in men. Nodular hyperplasia and
adenocarcinoma are common causes of prostatic enlargement. Diagnosis of these lesions …

Иммунологические аспекты диагностики рака предстательной железы

СВ Попов, РГ Гусейнов, ИН Орлов… - Вестник …, 2018 - cyberleninka.ru
Актуальность. Своевременная диагностика рака предстательной железы имеет
решающее значение для дальнейшей судьбы пациента. Затруднения при …

Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population

D Taheri, E Roohani, MH Izadpanahi… - Journal of Research …, 2021 - journals.lww.com
Background: Considering the great variations in the reported prevalence of prostate cancer
across the world possibly due to different genetic and environmental backgrounds, we …

Expression of p63 protein to differentiate benign prostatic hyperplasia and carcinoma of prostate in Pakistani population

B Nisar, N Sarwar, S Sharif, A Hameed… - Annals of King Edward …, 2017 - annalskemu.org
Background: Prostate cancer is the world's foremost and second cause of cancer associated
death typically in males after lung cancer. Histopathological diagnosis of prostatic …

[HTML][HTML] Role of Triple Antibody Cocktail, α-methyl acyl-CoA Racemase (AMACR/P504S), high-molecular-weight cytokeratin (HMWCK 34βE12), and Transformation …

B Iqbal, PL Nibe, C Gore, G Bhuibhar… - Medical Journal of Dr …, 2024 - journals.lww.com
Background: One of the most prevalent cancers in males worldwide is prostate cancer.
Numerous benign conditions, including adenosis, atrophy, partial atrophy, basal cell …